Novel quercetin derivatives: From redox properties to promising treatment of oxidative stress related diseases

Chemico-Biological Interactions

Volumn 265, Issue , 2017, Pages 36-46

  Zizkova, Petronela ^a   Stefek, Milan ^a   Rackova, Lucia ^a   Prnova, Marta ^a   Horakova, Lubica ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Aldose reductase; Anticancer and antiinflammatory effect; Antidiabetic; Ca2+ ATPase

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ACETIC ACID; ACETYLCHLOROGENOYLQUERCETIN; ACETYLDIDIACETYLCAFFEOYLQUERCETIN; ADENOSINE TRIPHOSPHATASE (CALCIUM); ALDEHYDE REDUCTASE; ALPHA GLUCOSIDASE; CHLORONAPHTHOQUINONEQUERCETIN; DIDIACETYLCAFFEOYLQUERCETIN; DIPRENOCAFFEOYLQUERCETIN; DIPRENYLFERULOYLQUERCETIN; DITETRAACETYLFERULOYLQUERCETIN; MONOACETYLFERULOYLQUERCETIN; MONOCHLOROPIVALOYLQUERCETIN; PEROXYNITRITE; QUERCETIN DERIVATIVE; TETRATRIMETHYLGALOYLOXYFERULOYLQUERCETIN; THIOL; TRIACETYLCAFFEOYLQUERCETIN; TRIACETYLFERULOYLQUERCETIN; TRICHLOROPIVALOYLQUERCETIN; UNCLASSIFIED DRUG; QUERCETIN;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; BINDING AFFINITY; CELL FREE SYSTEM; COLITIS; COLORECTAL CANCER CELL LINE; DPPH RADICAL SCAVENGING ASSAY; DRUG CYTOTOXICITY; DRUG STRUCTURE; ENZYME INHIBITION; FERRIC REDUCING ANTIOXIDANT POWER ASSAY; FIBROBLAST CULTURE; HUMAN; LIPOPHILICITY; MICROGLIA; NONHUMAN; OXIDATION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; QUANTUM CHEMISTRY; REVIEW; SARCOPLASMIC RETICULUM; ANIMAL; CHEMISTRY; DIABETES MELLITUS; DRUG EFFECTS; INFLAMMATION; METABOLISM; OXIDATION REDUCTION REACTION;

ANIMALS; DIABETES MELLITUS; HUMANS; INFLAMMATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; QUERCETIN;

EID: 85012284032     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2017.01.019     Document Type: Review

References (74)

1. [1] Sies, H., Oxidative stress: a concept in redox biology and medicine. Redox Biol. 4 (2015), 180–183.
2. [2] Muriach, M., Flores-Bellver, M., Romero, F.J., Barcia, J.M., Muriach, M., et al. Diabetes and the brain: oxidative stress, inflammation, and autophagy. Oxid. Med. Cell. Longev., 2014, 2014, 102158.
3. [3] Queen, B.L., Tollefsbol, T.O., Polyphenols and aging. Curr. Aging Sci. 3 (2010), 34–42.
4. [4] Petersen, K.S., Smith, C., Petersen, K.S., Smith, C., Ageing-Associated oxidative stress and inflammation are alleviated Byproducts from grapes. Oxid. Med. Cell. Longev. 2016 (2016), 1–12.
5. [5] Lesser, Lesser, S., Oral bioavailability of the flavonol quercetin a review. Curr. Top. nutraceuticals Res., 4, 2006.
6. [6] Stefek, M., Karasu, C., Eye lens in aging and diabetes: effect of quercetin. Rejuvenation Res. 14 (2011), 525–534.
7. [7] Bors, W., Michel, C., Chemistry of the antioxidant effect of polyphenols. Ann. N. Y. Acad. Sci. 957 (2002), 57–69.
8. [8] Matsuda, H., Wang, T., Managi, H., Yoshikawa, M., Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg. Med. Chem. 11 (2003), 5317–5323.
9. [9] Amic, D., Davidovic-Amic, D., Beslo, D., Rastija, V., Lucic, B., et al. SAR and QSAR of the antioxidant activity of flavonoids. Curr. Med. Chem. 14 (2007), 827–845.
10. [10] Croft, K.D., The chemistry and biological effects of flavonoids and phenolic acids. Ann. N. Y. Acad. Sci. 854 (1998), 435–442.
11. [11] Bors, W., Heller, W., Michel, C., Saran, M., Flavonoids as antioxidants: Determination of radical-scavenging efficiencies. Methods Enzymol. 186 (1990), 343–355.
12. [12] Flora, S.J.S., Structural, chemical and biological aspects of antioxidants for strategies against metal and metalloid exposure. Oxid. Med. Cell. Longev. 2 (2009), 191–206.
13. [13] Kumar, S., Pandey, A.K., Kumar, S., Pandey, A.K., Chemistry and biological activities of flavonoids: an overview. Sci. World. J., 2013, 2013, 162750.
14. [14] Veverka, M., Gallovič, J., Švajdlenka, E., Veverková, E., Prónayová, N., Miláčková, I., Štefek, M., Novel quercetin derivatives: synthesis and screening for anti-oxidant activity and aldose reductase inhibition. Chem. Pap. 67 (2013), 76–83.
15. [15] Milackova, I., Kovacikova, L., Veverka, M., Gallovic, J., Stefek, M., Screening for antiradical efficiency of 21 semi-synthetic derivatives of quercetin in a DPPH assay. Interdiscip. Toxicol. 6 (2013), 13–17.
16. [16] BLOIS, M.S., Antioxidant Determinations by the use of a stable free radical. Nature 181 (1958), 1199–1200.
17. [17] Ratty, A.K., Sunamoto, J., Das, N.P., Interaction of flavonoids with 1,1-diphenyl-2-picrylhydrazyl free radical, liposomal membranes and soybean lipoxygenase-1. Biochem. Pharmacol. 37 (1988), 989–995.
18. [18] Žižková, P., Blaškovič, D., Májeková, M., Švorc, L., Račková, L., et al. Novel quercetin derivatives in treatment of peroxynitrite-oxidized SERCA1. Mol. Cell. Biochem. 386 (2014), 1–14.
19. [19] Schaich, K.M., Tian, X., Xie, J., Hurdles and pitfalls in measuring antioxidant efficacy: a critical evaluation of ABTS, DPPH, and ORAC assays. J. Funct. Foods 14 (2015), 111–125.
20. [20] Danihelová, M., Veverka, M., Sturdík, E., Jantová, S., Antioxidant action and cytotoxicity on HeLa and NIH-3T3 cells of new quercetin derivatives. Interdiscip. Toxicol. 6 (2013), 209–216.
21. [21] Liebeke, M., Pöther, D.-C., van Duy, N., Albrecht, D., Becher, D., et al. Depletion of thiol-containing proteins in response to quinones in Bacillus subtilis. Mol. Microbiol. 69 (2008), 1513–1529.
22. [22] Forman, H.J., Davies, K.J.A., How do nutritional antioxidants really work: Nucleophilic tone and para-hormesis versus free radical scavenging in vivo. Free Radic. Biol. Med. 66 (2014), 24–35.
23. [23] Kuniaková, M., Mrvová, N., Knezl, V., Račková, L., Effect of novel quercetin pivaloyl ester on functions of adult rat microglia. Biol. Bratisl. 70 (2015), 690–702.
24. [24] Mrvová, N., Škandík, M., Kuniaková, M., Račková, L., Modulation of BV-2 microglia functions by novel quercetin pivaloyl ester. Neurochem. Int. 90 (2015), 246–254.
25. [25] Milackova, I., Rackova, L., Majekova, M., Mrvova, N., Stefek, M., Protection or cytotoxicity mediated by a novel quinonoid-polyphenol compound?. Gen. Physiol. Biophys. 34 (2015), 51–64.
26. [26] Milackova, I., Prnova, M.S., Majekova, M., Sotnikova, R., Stasko, M., et al. 2-Chloro-1,4-naphthoquinone derivative of quercetin as an inhibitor of aldose reductase and anti-inflammatory agent. J. Enzyme Inhib. Med. Chem. 30 (2015), 107–113.
27. [27] Kundu, J., Kim, D.-H., Kundu, J.K., Chun, K.-S., Thymoquinone induces heme oxygenase-1 expression in HaCaT cells via Nrf2/ARE activation: Akt and AMPKα as upstream targets. Food Chem. Toxicol. 65 (2014), 18–26.
28. [28] Kocanova, S., Buytaert, E., Matroule, J.-Y., Piette, J., Golab, J., et al. Induction of heme-oxygenase 1 requires the p38MAPK and PI3K pathways and suppresses apoptotic cell death following hypericin-mediated photodynamic therapy. Apoptosis 12 (2007), 731–741.
29. [29] Divya, T., Dineshbabu, V., Soumyakrishnan, S., Sureshkumar, A., Sudhandiran, G., Celastrol enhances Nrf2 mediated antioxidant enzymes and exhibits anti-fibrotic effect through regulation of collagen production against bleomycin-induced pulmonary fibrosis. Chem. Biol. Interact. 246 (2016), 52–62.
30. [30] Verma, R.P., Anti-cancer activities of 1,4-naphthoquinones: a QSAR study. Anticancer. Agents Med. Chem. 6 (2006), 489–499.
31. [31] Enayat, S., Şeyma Ceyhan, M., Taşkoparan, B., Stefek, M., Banerjee, S., CHNQ, a novel 2-Chloro-1,4-naphthoquinone derivative of quercetin, induces oxidative stress and autophagy both in vitro and in vivo. Arch. Biochem. Biophys. 596 (2016), 84–98.
32. [32] Li, Y.-C., He, S.-M., He, Z.-X., Li, M., Yang, Y., et al. Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells. Cancer Lett. 344 (2014), 239–259.
33. [33] Singh, U.V., Udupa, N., Reduced toxicity and enhanced antitumor efficacy of betacyclodextrin plumbagin inclusion complex in mice bearing Ehrlich ascites carcinoma. Indian J. Physiol. Pharmacol. 41 (1997), 171–175.
34. [34] Sugie, S., Okamoto, K., Rahman, K.M.W., Tanaka, T., Kawai, K., et al. Inhibitory effects of plumbagin and juglone on azoxymethane-induced intestinal carcinogenesis in rats. Cancer Lett. 127 (1998), 177–183.
35. [35] Hsu, Y., Cho, C., Kuo, P., Huang, Y., Lin, C., Plumbagin ( 5-Hydroxy-2-methyl-1, 4-naphthoquinone ) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH 2 -Terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. J. Pharmacol. Exp. Ther. 318 (2006), 484–494.
36. [36] Morselli, E., Galluzzi, L., Kepp, O., Criollo, A., Maiuri, M.C., et al. Autophagy mediates pharmacological lifespan extension by spermidine and resveratrol. Aging (Albany. NY). 1 (2009), 961–970.
37. [37] Horáková, L., Strosova, M.K., Spickett, C.M., Blaskovic, D., Impairment of calcium ATPases by high glucose and potential pharmacological protection. Free Radic. Res. 47:Suppl 1 (2013), 81–92.
38. [38] Kulkarni, R.N., Roper, M.G., Dahlgren, G., Shih, D.Q., Kauri, L.M., et al. Islet secretory defect in insulin receptor substrate 1 null mice is linked with reduced calcium signaling and expression of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA)-2b and -3. Diabetes 53 (2004), 1517–1525.
39. [39] Herchuelz, A., Nguidjoe, E., Jiang, L., Pachera, N., β-Cell preservation and regeneration in diabetes by modulation of β-cell Ca2+ homeostasis. Diabetes, Obes. Metab. 14 (2012), 136–142.
40. [40] Inesi, G., Sumbilla, C., Kirtley, M.E., Relationships of molecular structure and function in Ca2(+)-transport ATPase. Physiol. Rev. 70 (1990), 749–760.
41. [41] MacLennan, D.H., Toyofuku, T., Lytton, J., Structure-function relationships in sarcoplasmic or endoplasmic reticulum type Ca2+ pumps. Ann. N. Y. Acad. Sci. 671 (1992), 1–10.
42. [42] Blaškovič, D., Zižková, P., Držík, F., Viskupičová, J., Veverka, M., et al. Modulation of rabbit muscle sarcoplasmic reticulum Ca(2+)-ATPase activity by novel quercetin derivatives. Interdiscip. Toxicol. 6 (2013), 3–8.
43. [43] Blaskovic, D., Drzik, F., Viskupicova, J., Zizkova, P., Veverka, M., et al. Effects of novel quercetin derivatives on sarco/endoplasmic reticulum Ca2+-ATPase activity. Neuro Endocrinol. Lett. 33:Suppl 3 (2012), 190–197.
44. [44] Lin, Y.T., Yang, J.S., Lin, H.J., Tan, T.W., Tang, N.Y., et al. Baicalein induces apoptosis in SCC-4 human tongue cancer cells via a Ca2+-dependent mitochondrial pathway. Vivo (Brooklyn). 21 (2007), 1053–1058.
45. [45] Ogunbayo, O.a, Harris, R.M., Waring, R.H., Kirk, C.J., Michelangeli, F., Inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase by flavonoids: a quantitative structure-activity relationship study. IUBMB Life 60 (2008), 853–858.
46. [46] Michelangeli, F., East, J.M., A diversity of SERCA Ca2+ pump inhibitors. Biochem. Soc. Trans. 39 (2011), 789–797.
47. [47] Beaumont, K., Webster, R., Gardner, I., Dack, K., Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist. Curr. Drug Metab. 4 (2003), 461–485.
48. [48] Parisini, E., Metrangolo, P., Pilati, T., Resnati, G., Terraneo, G., Halogen bonding in halocarbon-protein complexes: a structural survey. Chem. Soc. Rev. 40 (2011), 2267–2278.
49. [49] Vinayagam, R., Xu, B., Antidiabetic properties of dietary flavonoids: a cellular mechanism review. Nutr. Metab. (Lond)., 12, 2015, 60.
50. [50] Srivastava, S.K., Ramana, K.V., Bhatnagar, A., Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr. Rev. 26 (2005), 380–392.
51. [51] Alexiou, P., Pegklidou, K., Chatzopoulou, M., Nicolaou, I., Demopoulos, V.J., Aldose reductase enzyme and its implication to major health problems of the 21(st) century. Curr. Med. Chem. 16 (2009), 734–752.
52. [52] Chatzopoulou, M., Alexiou, P., Kotsampasakou, E., Demopoulos, V.J., Novel aldose reductase inhibitors: a patent survey (2006–present). Expert Opin. Ther. Pat. 22 (2012), 1303–1323.
53. [53] Veverka, M., Gallovič, J., Švajdlenka, E., Veverková, E., Prónayová, N., et al. Novel quercetin derivatives: synthesis and screening for anti-oxidant activity and aldose reductase inhibition. Chem. Pap. 67 (2013), 76–83.
54. [54] Soltesova-Prnova, M., Milackova, I., Stefek, M., 3′-O-(3-Chloropivaloyl)quercetin, α-glucosidase inhibitor with multi-targeted therapeutic potential in relation to diabetic complications. Chem. Pap., 0, 2016.
55. [55] Stefek, M., Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract. Interdiscip. Toxicol. 4 (2011), 69–77.
56. [56] Goodarzi, M.T., Zal, F., Malakooti, M., Safari, M.R., Sadeghian, S., Inhibitory activity of flavonoids on the lens aldose reductase of healthy and diabetic rats. Acta Med. Iran. 44 (2006), 41–45.
57. [57] Cao, H., Chen, X., Structures required of flavonoids for inhibiting digestive enzymes. Anticancer Agents Med. Chem. 12 (2012), 929–939.
58. [58] Xiao, J., Kai, G., Yamamoto, K., Chen, X., Advance in dietary polyphenols as α-glucosidases inhibitors: a review on structure-activity relationship aspect. Crit. Rev. Food Sci. Nutr. 53 (2013), 818–836.
59. [59] Jo, S.-H., Cho, C.-Y., Lee, J.-Y., Ha, K.-S., Kwon, Y.-I., et al. In vitro and in vivo reduction of post-prandial blood glucose levels by ethyl alcohol and water Zingiber mioga extracts through the inhibition of carbohydrate hydrolyzing enzymes. BMC Complement. Altern. Med., 16, 2016, 111.
60. [60] Yin, Z., Zhang, W., Feng, F., Zhang, Y., Kang, W., α-Glucosidase inhibitors isolated from medicinal plants. Food Sci. Hum. Wellness 3 (2014), 136–174.
61. [61] Chung, H.Y., Cesari, M., Anton, S., Marzetti, E., Giovannini, S., et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res. Rev. 8 (2009), 18–30.
62. [62] Wong, W.T., Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation. Front. Cell. Neurosci., 7, 2013, 22.
63. [63] Moura, F.A., de Andrade, K.Q., dos Santos, J.C.F., Araújo, O.R.P., Goulart, M.O.F., Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?. Redox Biol. 6 (2015), 617–639.
64. [64] Shapiro, H., Singer, P., Halpern, Z., Bruck, R., Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis. Gut 56 (2007), 426–435.
65. [65] Jang, S., Johnson, R.W., Can consuming flavonoids restore old microglia to their youthful state?. Nutr. Rev. 68 (2010), 719–728.
66. [66] Costa, L.G., Garrick, J.M., Roquè, P.J., Pellacani, C., Mechanisms of neuroprotection by quercetin: Counteracting oxidative stress and more. Oxid. Med. Cell. Longev., 2016, 2016.
67. [67] Rinwa, P., Kumar, A., Quercetin suppress microglial neuroinflammatory response and induce antidepressent-like effect in olfactory bulbectomized rats. Neuroscience 255 (2013), 86–98.
68. [68] Jung, S.H., Murphy, E.A., McClellan, J.L., Carmichael, M.D., Davis, J.M., The dietary flavonoid quercetin decreases neuroinflammation in a mouse model of Alzheimer's disease. FASEB J. 24 (2010), 604–617.
69. [69] Ossola, B., Kääriäinen, T.M., Männistö, P.T., The multiple faces of quercetin in neuroprotection. Expert Opin. Drug Saf. 8 (2009), 397–409.
70. [70] Lee, Y.S., Kim, S.H., Jung, S.H., Kim, J.K., Pan, C.-H., et al. Aldose reductase inhibitory compounds from Glycyrrhiza uralensis. Biol. Pharm. Bull. 33 (2010), 917–921.
71. [71] Jung, H.A., Yoon, N.Y., Kang, S.S., Kim, Y.S., Choi, J.S., Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldose reductase and generation of advanced glycation endproducts. J. Pharm. Pharmacol. 60 (2008), 1227–1236.
72. [72] Jung, H.A., Jung, Y.J., Yoon, N.Y., Jeong, D.M., Bae, H.J., et al. Inhibitory effects of Nelumbo nucifera leaves on rat lens aldose reductase, advanced glycation endproducts formation, and oxidative stress. Food Chem. Toxicol. 46 (2008), 3818–3826.
73. [73] Crespy, V., Morand, C., Besson, C., Manach, C., Demigne, C., et al. Quercetin, but not its glycosides, is absorbed from the rat stomach. J. Agric. Food Chem. 50 (2002), 618–621.
74. [74] Manach, C., Scalbert, A., Morand, C., Rémésy, C., Jiménez, L., Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79 (2004), 727–747.